MyAverix Finance
SHG · Healthcare
KPC Pharmaceuticals Inc (600422)
Drug Manufacturers - Specialty & Generic
KPC Pharmaceuticals Inc (600422) is listed on SHG in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-28, reported market cap is $8.63B, P/E ratio is 24.78, net margin is 5.3%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for 600422
KPC Pharmaceuticals Inc (600422) — FAQ
What is KPC Pharmaceuticals Inc's market cap?
KPC Pharmaceuticals Inc (600422) has a reported market cap of $8.63B (data as of 2026-03-28).
What is 600422's P/E ratio?
The price-to-earnings (P/E) ratio for KPC Pharmaceuticals Inc (600422) is 24.78 (data as of 2026-03-28).
Does KPC Pharmaceuticals Inc pay a dividend?
Dividend yield is not available in the current snapshot for KPC Pharmaceuticals Inc (600422). Check the MyAverix Finance app for the latest dividend data.
What sector is KPC Pharmaceuticals Inc in?
KPC Pharmaceuticals Inc (600422) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is 600422 listed on?
600422 is listed on SHG.
What is KPC Pharmaceuticals Inc's net margin?
KPC Pharmaceuticals Inc (600422) reports a net margin of 5.3% (data as of 2026-03-28).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.